Clinical trial
A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN #1203; Progress I)
NCT02208037 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN #1203; Progress I)
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2014
- Completion date
- October 31, 2017
- Enrollment
- 279 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.
acute leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, hodgkin's lymphoma, lymphoma, b-cell, lymphoma, follicular, lymphoma, large b-cell, diffuse, myelodysplasia, small lymphocytic lymphoma